143 related articles for article (PubMed ID: 17169394)
1. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
Paul TA; Casey JW; Avery RJ; Sutton CA
Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
[TBL] [Abstract][Full Text] [Related]
2. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the vif gene of feline immunodeficiency virus.
Shacklett BL; Luciw PA
Virology; 1994 Nov; 204(2):860-7. PubMed ID: 7941360
[TBL] [Abstract][Full Text] [Related]
4. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
[TBL] [Abstract][Full Text] [Related]
5. Comparative replication kinetics of two cytopathic feline lentiviruses ex vivo.
Sutton CA; Gordnier PM; Avery RJ; Casey JW
Virology; 2005 Feb; 332(2):519-28. PubMed ID: 15680417
[TBL] [Abstract][Full Text] [Related]
6. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.
Zielonka J; Marino D; Hofmann H; Yuhki N; Löchelt M; Münk C
J Virol; 2010 Jul; 84(14):7312-24. PubMed ID: 20444897
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
8. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
[TBL] [Abstract][Full Text] [Related]
9. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
10. The roles of vif and ORF-A genes and AP-1 binding site in in vivo replication of feline immunodeficiency virus.
Inoshima Y; Miyazawa T; Mikami T
Arch Virol; 1998; 143(4):789-95. PubMed ID: 9638148
[TBL] [Abstract][Full Text] [Related]
11. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
Gu Q; Zhang Z; Cano Ortiz L; Franco AC; Häussinger D; Münk C
J Virol; 2016 Dec; 90(23):10545-10557. PubMed ID: 27630243
[TBL] [Abstract][Full Text] [Related]
12. Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.
Troyer RM; Thompson J; Elder JH; VandeWoude S
J Virol; 2013 Jul; 87(14):7940-51. PubMed ID: 23658451
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins.
Kosugi Y; Uriu K; Suzuki N; Yamamoto K; Nagaoka S; Kimura I; Konno Y; Aso H; Willett BJ; Kobayashi T; Koyanagi Y; Ueda MT; Ito J; Sato K
J Virol; 2021 Jun; 95(13):e0017821. PubMed ID: 33762419
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
15. Proviral organization and sequence analysis of feline immunodeficiency virus isolated from a Pallas' cat.
Barr MC; Zou L; Long F; Hoose WA; Avery RJ
Virology; 1997 Feb; 228(1):84-91. PubMed ID: 9024812
[TBL] [Abstract][Full Text] [Related]
16. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
[TBL] [Abstract][Full Text] [Related]
17. Feline immunodeficiency virus Vif localizes to the nucleus.
Chatterji U; Grant CK; Elder JH
J Virol; 2000 Mar; 74(6):2533-40. PubMed ID: 10684267
[TBL] [Abstract][Full Text] [Related]
18. Functional domains in the feline immunodeficiency virus nucleocapsid protein.
Manrique ML; Rauddi ML; González SA; Affranchino JL
Virology; 2004 Sep; 327(1):83-92. PubMed ID: 15327900
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan 95, an amino acid residue of the Caprine arthritis encephalitis virus vif protein which is essential for virus replication.
Seroude V; Audoly G; Gluschankof P; Suzan M
Virology; 2001 Feb; 280(2):232-42. PubMed ID: 11162837
[TBL] [Abstract][Full Text] [Related]
20. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
